Kanghong Investigative Site

Austin, Texas 78705

We've found

2 trials

at this facility

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration (PANDA-2)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Austin, TX

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration (PANDA-1)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Austin, TX

Use our guide to learn which trials are right for you!